Literature DB >> 6630281

Biological activation of 1,3-butadiene to vinyl oxirane by rat liver microsomes and expiration of the reactive metabolite by exposed rats.

H M Bolt, G Schmiedel, J G Filser, H P Rolzhäuser, K Lieser, D Wistuba, V Schurig.   

Abstract

When 1,3-butadiene is incubated with rat liver microsomes and NADPH both enantiomers of vinyl oxirane are formed, the amount of epoxide being dependent on incubation time, microsomal protein, and substrate concentration. Inhibition by SKF 525 A or dithiocarb as well as induction by pretreatment with phenobarbital or 20-methylcholanthrene suggest participation of cytochrome P-450 in this reaction. The amount of epoxide is enhanced by addition of 1,1,1-trichloropropene oxide and reduced by glutathione, especially in the presence of hepatic cytosol. When rats are exposed to 1,3-butadiene in a closed chamber (conditions of maximal metabolism) vinyl oxirane is exhaled and can be quantitatively determined from the gas phase. The concurrent exhalation of acetone is consistent with the idea of biologic action of a reactive metabolite.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6630281     DOI: 10.1007/BF00395388

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  9 in total

1.  Liver microsomal uptake of (14C)vinyl chloride and transformation to protein alkylating metabolites in vitro.

Authors:  H Kappus; H M Bolt; A Buchter; W Bolt
Journal:  Toxicol Appl Pharmacol       Date:  1976-09       Impact factor: 4.219

2.  Mutagenicity of butadiene and butadiene monoxide.

Authors:  C de Meester; F Poncelet; M Roberfroid; M Mercier
Journal:  Biochem Biophys Res Commun       Date:  1978-01-30       Impact factor: 3.575

3.  Inhalation pharmacokinetics based on gas uptake studies. IV. The endogenous production of volatile compounds.

Authors:  J G Filser; H M Bolt
Journal:  Arch Toxicol       Date:  1983-02       Impact factor: 5.153

4.  Irreversible protein binding of metabolites of ethynylestradiol in vivo and in vitro.

Authors:  H Kappus; H M Bolt; H Remmer
Journal:  Steroids       Date:  1973-08       Impact factor: 2.668

5.  Pharmacokinetics of halogenated ethylenes in rats.

Authors:  J G Filser; H M Bolt
Journal:  Arch Toxicol       Date:  1979-06-08       Impact factor: 5.153

6.  Inhalation pharmacokinetics based on gas uptake studies. I. Improvement of kinetic models.

Authors:  J G Filser; H M Bolt
Journal:  Arch Toxicol       Date:  1981-07       Impact factor: 5.153

7.  Hepatic microsomal metabolism of 1,3-butadiene.

Authors:  E Malvoisin; M Roberfroid
Journal:  Xenobiotica       Date:  1982-02       Impact factor: 1.908

8.  Increased acetone exhalation induced by metabolites of halogenated C1 and C2 compounds.

Authors:  J G Filser; P Jung; H M Bolt
Journal:  Arch Toxicol       Date:  1982-01       Impact factor: 5.153

9.  Characteristics of haloethylene-induced acetonemia in rats.

Authors:  J G Filser; H M Bolt
Journal:  Arch Toxicol       Date:  1980-07       Impact factor: 5.153

  9 in total
  16 in total

1.  Enzyme specific kinetics of 1,2-epoxybutene-3 in microsomes and cytosol from livers of mouse, rat, and man.

Authors:  P E Kreuzer; W Kessler; H F Welter; C Baur; J G Filser
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

2.  In vitro biotransformation of 2-methylpropene (isobutene): epoxide formation in mice liver.

Authors:  M Cornet; W Sonck; A Callaerts; G Csanády; A Vercruysse; R J Laib; V Rogiers
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

3.  In vivo roles of conjugation with glutathione and O6-alkylguanine DNA-alkyltransferase in the mutagenicity of the bis-electrophiles 1,2-dibromoethane and 1,2,3,4-diepoxybutane in mice.

Authors:  Sung-Hee Cho; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2013-11-06       Impact factor: 3.739

4.  Evaluation of DNA damage by alkaline elution technique after inhalation exposure of rats and mice to 1,3-butadiene.

Authors:  R R Vangala; R J Laib; H M Bolt
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

5.  Species differences in the formation of butadiene monoxide from 1,3-butadiene.

Authors:  U Schmidt; E Loeser
Journal:  Arch Toxicol       Date:  1985-09       Impact factor: 5.153

6.  Inhalation pharmacokinetics of 1,2-epoxybutene-3 reveal species differences between rats and mice sensitive to butadiene-induced carcinogenesis.

Authors:  R Kreiling; R J Laib; J G Filser; H M Bolt
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

7.  Inhalation pharmacokinetics based on gas uptake studies. V. Comparative pharmacokinetics of ethylene and 1,3-butadiene in rats.

Authors:  H M Bolt; J G Filser; F Störmer
Journal:  Arch Toxicol       Date:  1984-10       Impact factor: 5.153

8.  Inhalation pharmacokinetics based on gas uptake studies. VI. Comparative evaluation of ethylene oxide and butadiene monoxide as exhaled reactive metabolites of ethylene and 1,3-butadiene in rats.

Authors:  J G Filser; H M Bolt
Journal:  Arch Toxicol       Date:  1984-10       Impact factor: 5.153

9.  Species differences in butadiene metabolism between mice and rats evaluated by inhalation pharmacokinetics.

Authors:  R Kreiling; R J Laib; J G Filser; H M Bolt
Journal:  Arch Toxicol       Date:  1986-04       Impact factor: 5.153

Review 10.  A brief survey of butadiene health effects: a role for metabolic differences.

Authors:  L S Birnbaum
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.